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In the UK, the two main treatments of invasive bladder cancer are radiotherapy or cystectomy. However, B50% of patients
undergoing radiotherapy fail to respond. If tumour radiosensitivity could be predicted in advance, it may be possible to improve
control rates significantly by selecting for radiotherapy those patients whose tumours are radiosensitive. Additionally, patients who
would benefit from surgery would be identified earlier. The alkaline comet assay (ACA) is a sensitive method for the detection of
DNA strand break damage in cells. In the present study, using six bladder cancer cell lines of differing radiosensitivities, cell survival
was compared to the manifestation of radiogenic DNA damage as assessed by ACA. For all the cell lines, the extent of comet
formation strongly correlates with cell killing (R
240.96), with a greater response being noted in radiosensitive cells. In repair studies,
measures of residual damage correlate with survival fraction at 2Gy (R
240.96), but for only five of the cell lines. Finally, cells from
human bladder tumour biopsies reveal a wide range of predicted radiosensitivies as determined by ACA. Overall, these studies
demonstrate ACA to be a good predictive measure of bladder cancer cell radiosensitivity at low dose, with potential clinical
application.
British Journal of Cancer (2003) 89, 2271–2276. doi:10.1038/sj.bjc.6601333 www.bjcancer.com
& 2003 Cancer Research UK
Keywords: bladder cancer; comet assay; radiosensitivity; DNA damage; radiotherapy
                                               
In the UK, bladder cancer is a common urological malignancy,
affecting more than 12500 individuals each year and causing
nearly 5000 deaths per annum (CRC, 2001). In all, 90% of bladder
cancers are transitional cell carcinomas (TCCs) and B30% of
bladder tumours are muscle invasive at presentation, a feature that
is associated with significant risk of metastasis (30–60%). Patients
with organ-confined, muscle-invasive tumours, (T2/3/4a) who are
deemed fit, are considered for potentially curative treatment in the
form of radical surgery (cystectomy) or radiotherapy. Radical
cystectomy (removal of the bladder and urinary diversion) is
associated with significant morbidity and a mortality rate of B2%
(Skinner et al, 1988; Studer et al, 1995). Furthermore, the necessary
creation of an abdominal wall stoma (ileal conduit) may impact on
quality of life, and erectile dysfunction is virtually universal. The
outcome following radical cystectomy varies with tumour stage,
with an overall 5-year survival of B40%.
Radical radiotherapy (RT) is the mainstay of bladder-sparing
treatment regimens. It avoids the trauma of major surgery and is
considered a primary treatment for patients deemed unfit for
surgery. However, RT is itself associated with dose-related
complications arising from bowel and bladder being included in
the radiation field. Furthermore, while for B50% of patients
radical RT results in effective local tumour control and acceptable
bladder function (Quilty et al, 1986; Jenkins et al, 1989), the
remaining patients suffer local recurrence. For this latter group,
the decision to treat with RT is disadvantageous, as these patients
have been unnecessarily exposed to additional risks of ionising
radiation. In addition, the time taken to recognise treatment failure
(3–6 months) may provide further opportunity for metastatic
spread, before secondary treatment (salvage cystectomy) is
undertaken. Also, the morbidity in patients undergoing salvage
cystectomy has been found to be significantly higher than in
patients undergoing primary cystectomy (Rosario et al, 2000).
Consequently, if a patient’s bladder tumour RT response could be
predicted in advance, RT could be promoted in patients with
tumours that are predicted to respond. Conversely, patients with
nonresponsive tumours could be identified and offered surgery at
an earlier stage. In this way, the overall local control rates could be
improved.
While much work has been undertaken to develop assays
capable of predicting tumour response to RT, none has been
successfully applied to clinical practice. However, ex vivo measures
of the surviving fraction of tumour cells at 2Gy (SF2) suggest that
intrinsic radiosensitivity (IRS) is a significant factor in determin-
ing tumour radiocurability (West, 1995; West et al, 1997).
However, the SF2 assay fails to provide information on a time
scale appropriate for treatment planning and also suffers from
limited success rates; in an unpublished study, o10% of bladder
tumours gave rise to colonies on soft agar (McKeown, McKelvey-
Martin and Ho, personal communication). In addition, the
relationship between clonogenic survival and clinical response is
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yfar from proven. The limitations of SF2 have stimulated research
into methods to provide a more rapid and complete measure of
IRS.
DNA is the most important cellular target for the lethal effects of
ionising radiation, with double-strand breaks (DSBs) proposed to
be the principal lesions responsible for radiogenic cell killing
(Ward, 1988; Iliakis, 1991). Unfortunately, the relative yield of
radiogenic DSBs is low, and high radiation doses tend to be
required to produce measurable levels; doses that are far greater
than those used clinically. Indeed, while a recent study using the
neutral comet assay to measure DSBs reports an association
between DSB manifestation and survival (Price et al, 2000), the
correlations were not definite, with one cell line yielding a false
impression of radiosensitivity at the high doses (30Gy) required
for the assay. This highlights a benefit of conducting predictive
tests of radiosensitivity at clinically relevant doses.
In contrast with DSBs, the yield of radiation-induced single-
strand breaks (SSBs) is far greater (Ward, 1988), and can be readily
measured at low clinically relevant doses of radiation. Further-
more, the mechanisms that are proposed to vary the yield of
radiation-induced DSBs formation are also expected to vary the
yield of radiation-induced SSBs (Ward, 1990). Consequently, the
extent of radiation-induced SSB formation can be considered a
valid surrogate marker of radiogenic DSB formation.
The alkaline comet assay (ACA) is a highly sensitive method for
the assessment of SSBs and alkali labile sites (ALSs), and can
readily detect levels of damage induced by clinically relevant doses
of radiation (Singh et al, 1994; Singh, 1996). In a previous study of
just three bladder cancer cell lines, an inverse correlation was
obtained between clonogenic survival and mean tail moment (TM)
for comet formation, suggesting that ACA could potentially be
used to predict the radio response of the single cell lines
(McKelvey-Martin et al, 1998).
In the present study, we report our evaluation of ACA as a
measure of bladder cancer cell radiosensitivity in vitro using a
panel of six bladder cancer cell lines, and demonstrate that the
extent of comet formation best reflects bladder cancer cell
radiosensitivity; these results are supported by two independent,
parallel studies using colorectal tumour cells (Dunne et al, 2003)
and bladder tumour cells (McKeown et al, 2003). We also report on
a preliminary study to determine the differing ACA radio response
of epithelial cells isolated from human bladder tumour biopsies.
MATERIALS AND METHODS
Cell lines and culture conditions
The six bladder cell lines used in this study (RT112, UM-UC-3,
HT1376, J82, T24 and RT4; derived from high-grade TCCs) were
purchased from American Tissue Culture Collection (Manassas,
USA) and the European Collection of Cell Cultures (Salisbury,
UK). All cells were cultured as monolayers in exponential growth
by subcultivation. The RT112 and HT1376 cells were cultured in
Eagle’s minimal essential medium (EMEM), with 10% foetal calf
serum (FCS), 1% nonessential amino acid and 1% penicillin–
streptomycin. For the J82 cell line, 1% sodium pyruvate and 1%
glutamax were also added. The UM-UC-3 cell line was cultured in
EMEM with 10% FCS, 1% penicillin–streptomycin and 1% sodium
pyruvate. The T24 cell line was cultured in McCoy’s medium with
10% foetal calf serum and 1% penicillin–streptomycin. The RT4
cell line was subcultivated in RPMI medium with 10% foetal calf
serum, 1% penicillin–streptomycin and 1% sodium pyruvate. All
the cell lines used in the present study were tested for mycoplasma
contamination and were determined to be free of contamination
(‘Mycoplasma Experience’, Reigate, Surrey, UK). Cells were
harvested at 70–80% confluence by washing with prewarmed
371C phosphate-buffered saline (PBS) and then trypsinisation
(0.1% trypsin, 0.4% EDTA in PBS) at 371C. Culture medium was
added to the cells before centrifugation at 1500r.p.m. for 5min.
The pellet was resuspended and incubated in culture medium
(371C, 30min) at 1 10
5cellsml
 1 (for ACA and clonogenic assay)
before use. All cultures were tested for viability following this
procedure by trypan blue exclusion and was consistently found to
be 499%.
Alkaline comet assay
‘Cell-slide’ preparation Radiation-induced SSB and ALS DNA
damage were assessed using a modified version of ACA, whereby
the cells were irradiated ‘set’ in agarose gels on microscope slides
(‘cell-slides’). This modified version of the comet assay increases
sensitivity by minimising the opportunity for repair of induced
damage prior to cell lysis (McKeown et al, 2003).
The ACA technique used was adapted from the initial protocol
of Singh et al (1988). Briefly, dakin-frosted slides were covered
with 100ml of 0.6% normal melting point agarose (dissolved in Ca-
and Mg-free PBS at 451C), and the agarose was allowed to solidify
under a coverslip on ice and then the coverslips were removed.
Aliquots (1ml) of harvested cells containing 1 10
5cells in culture
medium were then centrifuged at 1500r.p.m. for 5min. The pellets
were resuspended in 80ml of 0.6% low melting point agarose
(dissolved in Ca- and Mg-free PBS at 371C), layered onto the
normal melting point agarose and allowed to solidify under a fresh
coverslip on ice. For ‘repair-slides’ equal volumes (40ml) of cell
suspension (in RPMI medium) and 1.2% of low melting point
agarose (dissolved in RPMI medium containing 20% FCS held at
371C) were mixed, layered and allowed to solidify under a fresh
coverslip on ice. All the steps described were conducted under a
reduced light level to prevent additional DNA damage.
X-ray irradiations Cell-slides were irradiated on ice, using a
Pantak DXT300 X-ray machine (Radiotherapy Unit, Leicester
Royal Infirmary) operated at 300kVp (HVL of 3.5mm Cu). Up to
12 slides are placed flat, in a prescribed manner, on an aluminium
sheet in thermal contact with ice, 0.8cm from a 50cm FSD, 20cm
square, normal therapy applicator. The dose rate (0.98Gymin
 1)
and uniformity of the field (710%) were previously determined
for this configuration using thermoluminescent dosimeters (not
presented). Duplicate or triplicate slides were irradiated with a
dose of 2, 4 and 6Gy to generate an immediate damage dose
response. Additional duplicate or triplicate slides irradiated with
2.5Gy were used to monitor repair at 15 and 30min.
Lysis and electrophoresis For studies of immediate damage, slides
were irradiated and then placed immediately in cold lysis buffer
(2.5 M NaCl, 100mM Na2EDTA, 10mM Tris, pH 10 and 1% Triton
X-100 (added fresh), 41C) for a minimum of 1h. For repair studies,
after irradiation the ‘repair-slides’ were incubated in growth media
at 371C for 15 or 30min and then placed in lysis buffer. After lysis,
the slides were drained and placed in a horizontal gel electro-
phoresis tank, surrounded by ice and filled with fresh cold
electrophoresis buffer (300mM NaOH, 1mM Na2EDTA, pH 13) to a
level of B0.25cm above the slides. Slides were kept in the high pH
buffer for 20min, to allow DNA unwinding. Electrophoresis was
then carried out for 20min at 25V and 300mA. The slides were
then drained and flooded slowly with three changes of neutralisa-
tion buffer (0.4 M Tris, pH 7.5) for 5min each and then stained with
50ml of ethidium bromide (20mgml
 1) and covered with a
coverslip for immediate analysis.
Comet image capture and analysis A total of 50 cells per slide
were analysed to give a representative result for the population of
cells (Price et al, 2000). Comet image capture and analysis utilised
Komet software (Version 4, Kinetic Imaging Ltd, Bromborough,
UK) and an epifluorescence microscope (Olympus BH2) fitted with
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yan excitation filter of 515–535nm, a barrier filter of 590nm and a
100W mercury lamp, and operated at a magnification of  200.
The olive tail moment (OTM) was selected as the parameter that
best reflected DNA damage (defined as the fraction of tail DNA
(TDNA) multiplied by the distance between the profile centres of
gravity for DNA in the head and tail). OTM was measured from
three independent experiments, each containing duplicate or
triplicate measures and presented as the mean7s.e.
Clonogenic assay
Cells from exponentially growing culture were seeded in appro-
priate numbers in 60 15mm
2 Petri dishes with 10ml of
appropriate culture medium. Following 4h incubation at 371C,
cells were irradiated in the dishes with 2, 4 and 6Gy. Non-
irradiated cultures were processed in parallel. Dishes were
subsequently incubated at 371C in humidified 95% air, 5% CO2
atmosphere for 2–3 weeks. Cells were then fixed with 3:1
ethanol:acetic acid and stained with crystal violet. Colonies were
counted for the control and dose groups, and each experiment was
performed on at least three separate occasions in triplicate. The SF,
presented as the mean7s.e., was defined as the ratio of colonies
formed to cells plated (with correction for plating efficiency (PE)),
and calculated using the formula: SF¼colonies counted/(cells
seeded (PE/100)). PE was expressed as the number of colonies
scored as a percentage of the number of viable control cells plated.
This was 435% for all the cell lines.
Human bladder samples
Samples of human bladder cancer tissue were acquired from
eight patients undergoing transuretheral resection for suspected
muscle-invasive bladder cancer. Muscle invasion was confirmed
by subsequent histological analysis. Acquisition of tissue
specimens was approved by the local ethical committee. Samples
were transported to the laboratory in culture media (10ml)
immediately following resection. Only exophytic areas of
the tumour were sampled, avoiding subepithelial layers of
the bladder wall. The tumour material was finely chopped and
placed in 20ml of collagenase (1mgml
 1) in a shaking water
bath at 371C for 20min. The sample was then filtered through a
nylon mesh (120-gauge filter) and the filtrate was washed
three times with PBS. The resulting single cells were counted
and the viability was assessed by trypan blue exclusion. (typically
this was 480%; samples with lower levels of viability were
discarded).
To reduce infiltrating cells contaminating the cell suspension,
cells expressing human epithelial antigen (HEA) were selected via a
biomagnetic technique using HEA microbeads according to the
supplier’s instructions (Miltenyi Biotech, Bisley, UK). HEA is
widely expressed on cells of epithelial origin, including associated
tumour cells (Moldenhauer et al, 1987).
To account for variation between experiments, additional slides
were prepared using an established lymphoblastoid cell line (Raji)
and these were irradiated and analysed in parallel.
RESULTS
Figure 1A shows the radiation cell survival responses for the six
bladder cancer cell lines investigated, over a dose range of 0–6Gy,
as determined by clonogenic assay. The determined SF2 values are
as follows: RT4 0.9270.08; T24 0.9170.054; HT1376 0.970.052;
UM-UC-3 0.8170.051; RT112 0.6870.04; J82 0.5670.062. The
studied cell lines exhibit a range of radiogenic sensitivities, with
J82 being the most sensitive to radiation-induced cell killing, and
RT4 and HT1376 being the most resistant. Notably, one cell line,
T24, by virtue of its unusual dose–response curve, with a
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Figure 1 (A) The radiation cell survival curve responses for the six
bladder cancer cell lines investigated, over a dose range of 0–6Gy, as
determined by clonogenic assay. Survival was determined as the number of
colonies formed following X-ray exposure. (B) The extent of initial comet
formation, as measured by mean OTM, for the six bladder cancer cell lines,
over a dose range of 0–6Gy, as determined by ACA. For (A and B) each
data point is the mean of three independent experiments7s.e. (C) The
relationship between the measures of mean OTM for initial comet
formation, as measured by ACA, and the measures of clonogenic cell
survival, for all six bladder cancer cell lines at 0, 2, 4 and 6Gy. The data are
fitted with an exponential trend line and the slope and correlation
coefficient are deduced.
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yprominent shoulder and steep exponential, demonstrates relative
radioresistance at a low dose (2Gy) and relative radiosensitivity at
higher doses.
Figure 1B compares the measures of initial comet formation (as
assessed by mean OTM) for the six bladder cancer cell lines, over a
dose range of 0–6Gy, as determined by ACA. The plots reveal
clear dose–response curves for each cell line, with the most
radiosensitive cell line (J82) displaying the highest values (at 6Gy:
OTM 21.5; TM 67.5; % tail DNA (%TDNA) 69%), and the most
radioresistant cell line (RT4) the lowest (at 6Gy: OTM 9.3; TM
19.0; %TDNA 25.5). At 6Gy, the rank order for initial comet
formation matches the rank order of cell killing for all six cell lines
(J824T244RT1124UM-UC-34HT13764RT4). Furthermore,
the T24 cell line exhibits a relatively low measure of mean OTM
at a low dose (2Gy), but relatively greater measures at higher doses
(4 and 6Gy). Using the ACA method as described, at 2Gy there is a
significant difference for the measures of mean OTM between the
more radiosensitive (J82 and RT112) and radioresistant (T24 and
RT4) cell lines (Po0.05, Tukey one-way ANOVA).
The relationship between mean OTM for initial comet formation
and clonogenic cell survival is shown in Figure 1C. The high degree
of correlation between the collated measures for all six cell lines
(R
2¼0.9656) indicates that the measures of initial comet forma-
tion accurately reflects clonogenic survival for these six cell lines
over the dose range studied. For each individual cell line, the
determined slopes and correlation coefficients (R
2) for comet
formation vs survival are as follows: RT4 slope,  0.118 (R
2 0.9575);
T24 slope,  0.1226 (R
2 0.9785); HT1376 slope,  0.1074 (R
2
0.9485); UM-UC-3 slope,  0.0999 (R
2 0.9785); RT112 slope,
 0.1023 (R
2 0.9977); J82 slope,  0.1275 (R
2 0.9867), with the
values of the derived individual slopes varying by no more than
B15% of the collated value ( 0.1203).
Figure 2A illustrates the ACA assessment of damage repair as
determined by measurement of residual comets after incubation
(371C) of the ‘cell-slides’ (see Materials and Methods) for either 15
or 30min, after 2.5Gy irradiation. For the most radioresistant cell
lines (RT4 and HT1376), the majority of repair occurs by 15min,
while for the more radiosensitive cell lines (J82 and RT112), a
significant ACA measure of residual comet remains after 30min.
Figure 2B and C show the relationship between the measures of
residual comets at the two repair incubation time points (15 and
30min), as determined by ACA, and the determined SF2 values for
the five cell lines J82, RT112, UM-UC-3, HT1376 and RT4. For
these five cell lines, the measures of residual comet after 15 and
30min correlate with SF2 with R
2 values of 0.9776 and 0.9676,
respectively. However, the inclusion of the data for the T24 cell line
(light grey open triangle) significantly worsened the correlations,
yielding R
2 values of 0.39934 and 0.5097 for 15 and 30min repair,
respectively; for the T24 cells, there is a higher ACA measure of
residual comet manifest during repair incubation.
Figure 3 compares the ACA measures of initial comet formation
in a pilot study of epithelial cells prepared from biopsies of human
invasive bladder tumours (n¼8), over a dose range of 0 to –6Gy.
The plots of the mean OTM reveal clear dose–response curves,
with a 44-fold difference in the initial comet formation being
noted between the samples with the highest and lowest measures of
comet formation.
DISCUSSION
The development of rapid and valid predictive tests of cell
radiosensitivity has important implications for clinical practice;
allowing for the rational choice and tailoring of treatments to each
individual patient, based on that individual’s tissue–cell radiation
sensitivity (Peters and McKay, 2001). The comet assay is a
straightforward and highly sensitive method for assessing DNA
damage formation and repair at the individual cell level (Singh et al,
1988; Singh, 1996), and is particularly suitable for the measurement
of radiogenic damage (Olive, 1999). The assay is inexpensive, data
are available within 24h and only low numbers of cells are
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Figure 2 (A) The extent of damage repair as determined by ACA, after
irradiation with 2.5Gy of X-rays. Each data point is the mean or three
independent experiments7s.e. The dashed line represents the mean
‘background’ level for unirradiated/control cells. (B and C) The correlation
between the measures of residual damage at (B) 15 and (C) 30min, as
determined by ACA, and the determined SF2 values for the five cell lines
J82, RT112, UM-UC-3, HT1376 and RT4. Data points for T24 (open grey
triangles) were excluded from the analysis.
ACA predicts bladder cancer cell radiosensitivity
MAL Moneef et al
2274
British Journal of Cancer (2003) 89(12), 2271–2276 & 2003 Cancer Research UK
M
o
l
e
c
u
l
a
r
a
n
d
C
e
l
l
u
l
a
r
P
a
t
h
o
l
o
g
yrequired, allowing results to be generated from small clinical
biopsies. This technique is therefore ideal for clinical application.
In the present study, we demonstrate ACA to be capable of
predicting radiation cell survival for a panel of six bladder cancer
cell lines. For initial measures of comet formation, there is a strong
inverse correlation with clonogenic survival for all six cell lines,
with the most radiation-sensitive cell lines displaying the highest
measures and the most radioresistant cell lines the lowest.
Furthermore, for one cell line, T24, the notable relative change
in survival response, from being relatively radiation resistant to
relatively radiation sensitive with increasing dose, was mirrored in
the ACA response. For the studies of repair, which entailed
measures of residual comets at various repair time points, there
was good correlation with survival (SF2) for five of the six cell lines
investigated, with the apparent extent of repair being greater in the
radioresistant cell lines. However, the superior correlation of
clonogenic radiation survival with the extent of immediate comet
formation, for all six cell lines (including the anomalous behaviour
of T24), signifies that it is immediate comet formation that best
predicts survival for these cell lines. Virtually identical findings are
reported in the two accompanying articles (Dunne et al, 2003;
McKeown et al, 2003).
For each individual cell line, the measures of mean OTM
increase with dose due to the dose dependency of radiation-
induced DNA damage formation. However, a conclusion that it is
the differing levels of immediate radiogenic DNA damage noted
between cells, which is responsible for their differing radio-
sensitivities, conflicts with previous reports that fail to detect such
damage (SSB or DSB) differences/correlations using comet or
other assays (Olive et al, 1991; Evans et al, 1993; Woudstra et al,
1996). This may reflect the fact that studies that fail to correlate
initial damage or repair with cell survival tend to have compared
cell lines of different origins (Olive et al, 1991, 1994; Woudstra et al,
1996) which may have different DNA conformations and therefore
may exhibit considerable differences in radiogenic DNA damage
assays. However, studies using cell lines of the same origin at least
show correlations between survival and repair/residual damage
(Marples et al, 1998; Eastham et al, 1999). A further factor that may
influence the extent of comet formation is the nature of the DNA
anchoring matrix-associated regions (MARs). MARs allow the
maintenance of contiguous looped regions of nuclear DNA of
varying superhelical densities. Consequently, differences in the
character of MARs may result in weaker DNA–matrix associa-
tions, thereby allowing additional release of the adjacent/
contiguous loops of DNA resulting from the presence of
radiation-induced DNA damage. Indeed, studies of radiation-
sensitive and -resistant mutants have revealed differences in IRS to
correlate with DNA stability in the presence of DNA damage as
measured by DNA loop rewinding ability, and with changes in
nucleoid protein composition (Malyapa et al, 1994, 1996).
In the repair studies, it was noted that residual damage (as
assessed by measures of residual comets) correlate well with SF2
for five of the six cell lines, with repair being greater in the
radioresistant cell lines. The high degree of correlation between the
measures of residual comet and SF2 may reflect the inclusion and
contribution of the SSB components of DSBs (and other complex
lesions) in the ACA assessment of damage at the time points
studied. Many studies have shown that a greater abundance of
residual DSBs, after a period of repair, is associated with a higher
cellular radiosensitivity, for example (Zhou et al, 1998). However,
for one cell line (T24), measures of residual comet did not correlate
with SF2, there being a greater than expected level of residual
damage manifest during repair incubation for this cell line. This
may be due to the relative change in the survival of this cell line,
from being relatively radioresistant to relatively radiosensitive, at
doses 42Gy; at higher doses, the T24 cells may suffer
proportionally greater levels of damage. Alternatively, the rela-
tively slow repair of damage (SSB and ALS) may reflect a possible
deficiency in the base excision repair for T24 cells. Obviously, this
scenario would seriously confound attempts to predict radio-
sensitivity from estimates of repair determined by ACA. However,
the fact that the unusual survival curve response of T24 was also
reflected in the ACA response strongly supports the ability of one
assay (ACA) to predict the other (survival). Furthermore, this
relative change in survival highlights the benefit of conducting
predictive tests using clinically relevant doses of radiation. In this
particular system, the use of higher test doses (42Gy) would yield
a false impression of radiosensitivity for T24 at a low dose (2Gy).
However, this does not totally invalidate high-dose experiments.
In a preliminary pilot study, epithelial cells isolated from
invasive bladder cancer biopsies also reveal a range of radio
responses, as determined by ACA, encompassing the responses
noted for the most radiation-sensitive and -resistant cell lines (J82
and RT4, respectively). Most importantly, this demonstrates that
the comet assay is possible on cells from biopsy material. From our
investigations with cultured bladder cancer cell lines, we speculate
that the 44-fold difference in immediate comet formation in the
biopsy-derived epithelial cells potentially reflects similar variations
in tumour cell radiosensitivity, but the validity of this remains to
be substantiated. However, the observation of differing tumour cell
radioresponses, in particular the observation of high degrees of
possible radioresistance, may be significant as a contributing
factor to the current high level of invasive bladder cancer RT
failure (Shipley et al, 1985; Duncan and Quilty, 1986).
CONCLUSIONS
In the present study, we have shown that the initial levels of comet
formation, as determined by ACA, best predict bladder cancer cell
radiosensitivity at low clinically relevant doses of radiation. The
measures of repair correlate with cell survival (SF2), but for only
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Figure 3 Extent of initial comet formation, as measured by mean OTM,
for epithelial cells prepared from invasive bladder tumour biopsies, over a
dose range of 0–6Gy, as determined by ACA. Each data point is the mean
of duplicate or triplicate irradiations7s.e. Also shown is the extent of initial
comet formation for the bladder cancer cell lines J82 and RT4.
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isolated from human bladder cancer biopsies reveal a potential
range of predicted radiosensitivities as determined by ACA at
clinically relevant radiation doses, and we speculate that this
variation in radiosensitivity may reflect the widely differing
response of bladder tumours to RT in vivo. Overall, our studies
demonstrate ACA to be a good predictive measure of bladder
cancer cell radiosensitivity. Further studies are required to evaluate
the ACA method fully as a valid predictive test of bladder tumour
cell radiosensitivity in the clinical treatment of invasive disease.
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